Increased CSF HVA response to arecoline challenge in Alzheimer's disease
- PMID: 1281646
- DOI: 10.1007/BF01250518
Increased CSF HVA response to arecoline challenge in Alzheimer's disease
Abstract
The effects of the muscarinic agonist, arecoline, on the concentration of homovanillic acid (HVA) in the cerebrospinal fluid of patients with Alzheimer's disease (AD) and controls were examined. Patients and controls received intravenous infusions of arecoline and a lumbar puncture was performed four hours after the infusion began. Arecoline induced a significant increase in the concentration of HVA in cerebrospinal fluid of Alzheimer's disease patients (p < .01) but not in controls. The differential HVA response to a muscarinic agonist in Alzheimer's disease is suggestive of an alteration in muscarinic receptor response. This finding may have potential implications for the pathophysiology and treatment of Alzheimer's disease.
Similar articles
-
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850
-
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.J Neurol Neurosurg Psychiatry. 1984 May;47(5):481-4. doi: 10.1136/jnnp.47.5.481. J Neurol Neurosurg Psychiatry. 1984. PMID: 6204017 Free PMC article.
-
5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.Neuro Endocrinol Lett. 2004 Dec;25(6):435-7. Neuro Endocrinol Lett. 2004. PMID: 15665806
-
Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.PLoS One. 2017 Feb 6;12(2):e0171524. doi: 10.1371/journal.pone.0171524. eCollection 2017. PLoS One. 2017. PMID: 28166276 Free PMC article.
-
Possible muscarinic supersensitivity in Alzheimer's disease.Prog Clin Biol Res. 1989;317:1223-33. Prog Clin Biol Res. 1989. PMID: 2690092 Review.
Cited by
-
Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer's Disease.J Alzheimers Dis Rep. 2018 Oct 3;2(1):165-167. doi: 10.3233/ADR-180077. J Alzheimers Dis Rep. 2018. PMID: 30480259 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical